Taken together, our data and previous reports indicate that basal levels of IRF5, preceding‐SARS‐CoV‐2 infection, are dysregulated in T2D patients; our supposition is comforted by a recent opinion article describing the hypothetical molecular mechanisms (Laviada‐Molina et al, 2020). This evidence concerns the gene IRF5 and type 2 diabetes mellitus.